Clinical and autonomic features of patients with autonomic failure

Patient noSexFinal diagnosisPresent age (y)Follow up (y)AF onset (y)RBD onset (y)C sign onset (y)E sign onset (y)SPD (mm Hg)DPD (mm Hg)Rest NA (pg/ml)Tilt NA (pg/ml)Δ NA (pg/ml)
1MPAF67552−61−243860+22
2MPAF67562−85−313865+27
3MPAF46637−40−2037144+107
4FPAF71663−76−23187122−65
5FPAF74756−54−1524240
6MPAF55546−80−351627+11
7FMSA583525258−27072126+54
8MMSA71660406868−106−517286+14
9MMSA61355545656−24−6229402+173
10MMSA672646065−49−11226406+180
  • AF onset=age at onset of autonomic failure; RBD onset=age at onset of RBD; follow up=duration of observation from first presentation at our Institute until final diagnosis; C sign onset=age at onset of cerebellar signs; E sign onset=age at onset of extrapyramidal signs; SPD=systolic blood pressure decrease (mm Hg) on tilt test at the first observation; DPD=diastolic blood pressure decrease (mm Hg) on tilt test at the first observation; rest NA=noradrenaline concentrations at rest (supine) at the first observation (normal values from 29 age matched healthy controls: 242 (SD 100) pg/ml; range 108-500 pg/ml); tilt NA=norepinephrine concentrations after 10 minutes head up tilt at the first observation (normal values from 29 age matched healthy controls: 441 (SD 147) pg/ml; range 246-836 pg/ml); ΔNA=difference in noradrenaline concentrations between 10 minutes head up tilt and baseline values at the first observation (normal values from 29 age matched healthy controls: 199 (SD 77 pg/ml) range 111-366 pg/ml).